Incidence and seroprevalence of hepatitis E virus infection in pregnant women infected with hepatitis B virus and antibody placental transfer in infants

Highlights • HBV-infected women rarely have novel HEV infection during late pregnancy. • Anti-HEV IgG in pregnant women has no adverse maternal and neonatal outcomes. • Maternal anti-HEV IgG may efficiently transfer into the fetuses.

Saved in:
Bibliographic Details
Published inJournal of clinical virology Vol. 82; pp. 84 - 88
Main Authors Huang, Hongyu, Xu, Chenyu, Zhou, Xuan, Liu, Lanhua, Dai, Yimin, Xu, Biao, Yang, Jishi, Chen, Tingmei, Hu, Yali, Zhou, Yi-Hua
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.09.2016
Subjects
Adult
Allergy and Immunology
China
Coinfection - epidemiology
Enzyme-Linked Immunosorbent Assay
Female
Follow-Up Studies
Hepatitis Antibodies - blood
Hepatitis B - complications
Hepatitis B virus (HBV)
Hepatitis E - epidemiology
Hepatitis E virus (HEV)
Humans
Immunity, Maternally-Acquired
Immunoglobulin G - blood
Immunoglobulin M - blood
Incidence
Infant
Infant, Newborn
Infectious Disease
Male
Maternal-Fetal Exchange
Pregnancy
Pregnancy Complications, Infectious - epidemiology
Pregnant women
Seroepidemiologic Studies
Time Factors
Transplacental transfer of anti-HEV
Young Adult
Pregnant women
Hepatitis B virus (HBV)
Transplacental transfer of anti-HEV
Hepatitis E virus (HEV)
Online AccessGet full text

Cover

More Information
Summary:Highlights • HBV-infected women rarely have novel HEV infection during late pregnancy. • Anti-HEV IgG in pregnant women has no adverse maternal and neonatal outcomes. • Maternal anti-HEV IgG may efficiently transfer into the fetuses.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1386-6532
1873-5967
DOI:10.1016/j.jcv.2016.07.010